中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中性粒细胞与淋巴细胞比值对慢加急性肝衰竭患者短期预后的评估价值

吴杜娟 金蕾 郜玉峰 叶珺 夏国美 李芳 邹桂舟

引用本文:
Citation:

中性粒细胞与淋巴细胞比值对慢加急性肝衰竭患者短期预后的评估价值

DOI: 10.3969/j.issn.1001-5256.2018.09.023
基金项目: 

安徽省自然科学基金资助项目(1608085MH164); 

详细信息
  • 中图分类号: R575.3

Value of neutrophil-lymphocyte ratio in evaluating the short-time prognosis of patients with acute-on-chronic liver failure

Research funding: 

 

  • 摘要:

    目的研究中性粒细胞与淋巴细胞比值(NLR)对HBV相关慢加急性肝衰竭(ACLF)患者28 d预后的影响。方法回顾性分析2015年1月-2016年12月在安徽医科大学第二附属医院住院的HBV-ACLF患者100例,根据患者第28 d表现出的疾病转归状况进行分组,分别归为死亡组(n=42)或者生存组(n=58),收集两组性别、年龄、实验室指标、MELD评分以及临床并发症情况,并对上述指标进行单因素分析,计量资料组间比较采用t检验或者Mann-Whithey U检验;计数资料组间比较采用χ2检验。多因素分析采用二元logistic回归分析。MELD评分与NLR的关系采用Pearson相关性分析,并通过受试者工作特征曲线(ROC曲线)分析不同预测指标对HBV-ACLF预后的临床价值。结果对100例HBV-ACLF患者分析显示,死亡组的年龄、Alb、ALT、肌酐、WBC、中性粒细胞计数、淋巴细胞计数、单核细胞计数、国际标准化比值、TBil、NLR、MELD评分与生存组比较,差异均有统计学意义(P值均<0.05)。生存组肝性脑病、出血、腹水、感染的发生率均低于死亡组,但组间差异均无统计学意义...

     

  • [1]ZHANG GL, GAO ZL.The immunological characteristics of and treatment strategies for HBV related acuteonchronic liver failure[J].Chin J Viral Dis, 2011, 1 (1) :5-8. (in Chinese) 张耿林, 高志良.乙型肝炎相关慢加急性肝衰竭的免疫学特征及治疗策略[J].中国病毒病杂志, 2011, 1 (1) :5-8.
    [2]BHAT T, TELI S, RIJAL J, et al.Neutrophil to lymphocyte ratio and cardiovascular diseases:A review[J].Expert Rew Cardiovasc Ther, 2013, 11 (1) :55-59.
    [3]OEHADIAN A, SURYADINATA H, DEWI S, et al.The role of neutrophyl lymphocyte count ratio as an inflammatory maker in systemic lupus erythematosus[J].Acta Med Indones, 2013, 45 (3) :170-174.
    [4]WU Y, CHEN HL, ZHANG JH, et al.Correlation between neutrophil to lymphocyte ratio and coronary lesion severity in patients with acute myocardial infarction[J].Clin J Med Offic, 2016, 44 (9) :910-913. (in Chinese) 吴恽, 陈洪亮, 张君海, 等.中性粒细胞/淋巴细胞比值与急性心肌梗死相关性研究[J].临床军医杂志, 2016, 44 (9) :910-913.
    [5]YILMAZ H, YALCIN KS, NAMUSLU M, et al.Neutrophil-lymphocyte ratio (NLR) could be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis (NASH) [J].Ann Clin Lab Sci, 2015, 45 (3) :278-286.
    [6]ZHANG H, SUN Q, MAO W, et al.Neutrophil-to-lymphocyte ratio predicts early mortality in patients with HBV-related decompensated cirrhosis[J].Gastroenterol Res Pract, 2016, 2016:4394650.
    [7]KWON JH, JANG JW, KIM YW, et al.The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis[J].BMC Gastroenterol, 2015, 15:146.
    [8]XU X, CHEN W, ZHANG L, et al.Prognostic significance of neutrophil to lymphocyte ratio in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization[J].Chin Med J (Engl) , 2014, 127 (24) :4204-4209.
    [9]LIU H, ZHANG H, WAN G, et al.Neutrophil-lymphocyte ratio:A novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure[J].J Viral Hepat, 2014, 21 (7) :499-507.
    [10] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases CMA;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, CMA.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.
    [11]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
    [12]ZOU Z, XU D, LI B, et al.Compartmentalization and its implication for peripheral immunologically-competent cells to the liver in patients with HBV-related acute-on-chronic liver failure[J].Hepatol Res, 2009, 39 (12) :1198-1207.
    [13] HUANG SJ, WANG XL, CHENG ZJ, et al.Expression of IP-10mRNA in peripheral blood mononuclear cells is correlated with serum levels of HBs Ag and HBV DNA and of value for prognosis in patients with HBV-related acute on chronic liver failure[J].Chin JClin Infect Dis, 2016, 9 (1) :1-6. (in Chinese) 黄少军, 王晓霖, 程正江, 等.HBV相关慢加急性肝衰竭患者IP-10mRNA表达与HBs Ag和HBV DNA的相关性及其在预后评估中的价值[J].中华临床感染病杂志, 2016, 9 (1) :1-6.
    [14]LU X, HAN T, LI Y, et al.Changes in levels of hepatitis B virus markers in patients with acute-on-chronic liver failure and chronic liver failure and their relationships with MELD scores[J].Shandong Med J, 2015, 55 (27) :1-3. (in Chinese) 鲁绪, 韩涛, 李莹, 等.慢加急性肝衰竭、慢性肝衰竭患者血清HBV标志物水平变化及其与MELD评分的关系[J].山东医药, 2015, 55 (27) :1-3.
    [15]AGIASOTELLI D, ALEXOPOULOU A, VASILIEVA L, et al.E-valuation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event[J].Hepatol Res, 2016, 46 (6) :514-520.
    [16]SHI XX, ZHANG YQ, ZHU P, et a I.Prognostic risk factors in patients with acute-on-chronic hepatitis B Iiver failure[J].J CIin Hepatol, 2016, 32 (4) :700-705. (in Chinese) 石新星, 张艳琼, 朱鹏, 等.乙型肝炎相关慢加急性肝衰竭患者预后的危险因素分析[J].临床肝胆病杂志, 2016, 32 (4) :700-705.
  • 加载中
计量
  • 文章访问数:  2262
  • HTML全文浏览量:  30
  • PDF下载量:  385
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-03-29
  • 出版日期:  2018-09-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回